VERNON, BC, November 25, 2022 /CNW/ – Doseology Sciences Inc. (CSE: THE CASE) (OTCQB: DOSEF) (FSE: VU7) (“Doseology” or the “Company”), a life sciences company focused on mental health and wellness, is excited to announce that its functional nutritional supplements will soon be available nationwide in all 14 of the top Whole Market locations. Find Canadian food.
The company launched with 3 flagship SKUs – functional mushroom tinctures SLEEP, WAKE, and ELEVATE. Doseology products can now be found at Whole Foods Market’s western grocery locations West Vancouver, North Vancouver, Vancouverand North Burnabyand will soon be available in all Canadian retail locations.
“Whole Foods has a reputation as an industry leader with the highest standards, which makes it an ideal retail partner for our products. This placement will help us generate brand awareness and increase sales, while also driving results.” providing health and wellness to consumers,” he said. Ralph OlsonCEO of the company.
The range is made with 100% fruit body mushrooms and adaptogenic herbs, and is designed for health seekers interested in daily support for cognition, mood, immunity and relaxation.
About 30% of Canadians suffer from a sleep disorder (The Sleep Foundation). Sleep affects mental and physical health, and is linked to many mood disorders, including depression and anxiety (Provincial Health Services Authority). To solve this problem, Doseology formulated SLEEP tincture The proprietary combination of reishi mishroom, chamomile and melatonin is a powerful tool that puts the body and mind in a state of calm and improves the quality of sleep. Reishi mushroom (Ganoderma lucidum), also known as the “Mushroom of Immortality”, has been used for centuries. relieve stress and anxiety.
Mornings are increased by Dosology WAKING UP tincture It’s an energetic blend of lion’s mane mushroom, yerba mate and B vitamins to promote alertness and mental clarity. Wake was last seen in Elle Gourmet”Four surprising health trends for 2023“.
The Doseology ELEVATE The tincture contains lion’s mane, a mushroom known to unlock cognitive potential, and is formulated with a nutrient-rich dose of ginger and vitamin B3. These ingredients consciously work together to provide support for the overall psyche.
On behalf of Doseology Sciences Inc.
Chief Executive Officer
About Whole Foods Market
For more than 40 years, Whole Foods Market has been a leading natural and organic food retailer. Whole Foods seeks out the finest natural and organic foods available, maintains the strictest quality standards in the industry, and has an unparalleled commitment to sustainable agriculture. Whole Foods has more than 500 stores in the United States, Canada and the United Kingdom. It has 14 sales locations Canadathere are 7 of them British Columbiaand 7 are included Ontario. Whole Foods is an Amazon subsidiary (Nasdaq: AMZN).
About Dosology Sciences (CSE: MOOD) (OTCQB: DOSEF) (FSE: VU7)
Doseology Sciences Inc. builds a thriving brand focused on mental health and wellness by cultivating, extracting and producing innovative nutraceuticals and pharmaceuticals. Doseology aims to make a meaningful impact on the mental health pandemic through the use and development of fungi and plant-based medicines. With a vertically integrated approach, Doseology intends to process and distribute products at its in-house facilities. Vernon, British Columbia, in accordance with applicable laws to ensure safe and quality production. Doseology’s medicinal mushroom products, including tinctures, powders, and supplements, are available at doseology.com.
This press release contains statements that constitute “forward-looking information” within the meaning of applicable securities laws. Forward-looking statements are generally identified by the words “may”, “may”, “may”, “should”, “will”, “intend”, “plan”, “anticipate”, “believe”, “estimate”. “hope” or similar expressions. Readers are cautioned that forward-looking information is not based on historical facts but instead reflects the Company’s management’s expectations, estimates or forecasts regarding the Company’s future business results or events based on management’s opinions, estimates and assumptions historically deemed reasonable. . announcements are made. Although the Company believes that the expectations reflected in this forward-looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on this information, as unknown or unpredictable factors may adversely affect materially on future results, perform. , or achievements. Among the key factors that could cause actual results to differ from those anticipated in the forward-looking information are: changes in general economic, business and political conditions, including changes in financial markets; the prevailing prices of products in the markets in which the Company operates decrease; Adverse changes in applicable laws or adverse changes in the application or enforcement of existing laws; regulations and enforcement priorities of government authorities; compliance with government regulation and related costs; and other risks described in the Company’s prospectus. If one or more of these risks or uncertainties materialize, or the assumptions underlying the forward-looking information prove incorrect, actual results may differ from those expressed herein as intended, planned, anticipated, believed, or estimated. or expected to differ. Although the Company has attempted to identify significant risks, uncertainties and factors that could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. . The Company does not intend, and assumes no obligation, to update this forward-looking information except as required by law. For more information, investors should review the Company’s filings available at CEDAR.
No securities regulatory agency has endorsed or approved the content of this press release. The Company’s securities have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, or state securities laws, and may not be offered or sold. United Statesor for the account or benefit of any person therein United States, registration of absence, or a valid exemption from registration requirements. This press release does not constitute an offer to sell or the solicitation of an offer to buy securities United Statesor in any other jurisdiction where the offer, solicitation or sale would be illegal.
CSE accepts no responsibility for the adequacy or accuracy of this release.
SOURCE Doseology Sciences Inc.
For multimedia downloads see original content: http://www.newswire.ca/en/releases/archive/November2022/25/c5549.html